Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136054 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chander Peddaboina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX 77807, USA. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, Histocompatibility Antigens Class II, Antigen Presentation, Autophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health (NIH), Baylor Scott and White Foundation.
Abstract (Originalsprache)
B cells contribute to innate and adaptive immunity. In the former, Toll-like receptor (TLR) activation promotes the expansion of inflammatory B cells. In the latter, B cell receptor (BCR) activation results in the production of antibodies or autoantibodies. Antigen processing and presentation are closely associated with major histocompatibility class II (MHC-II) and its companion protein, class II invariant peptide (CLIP). The impact of autophagy on the regulation of these unique mechanisms of B cell activation and subset expansion has not been fully explored. The results from the current study show that activating autophagy with rapamycin (RAPA) or inhibiting autophagy with hydroxycholoroquine (HCQ) differentially influences the TLR9 and BCR activation of B cells. These differences include the selective expansion of B1 and B2 B cell subsets, the regulation of the cell-surface expression of MHC-II and CLIP, and the ability of distinct B cell subsets to present peptide antigens. These novel findings demonstrate that the unique B cell activation mechanisms induced by TLR9 and BCR activation are differentially influenced by RAPA and HCQ, owing to the selective modulation of B cell subset expansion, and antigen processing and presentation by MHC-II proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX 77807, USA.
- Department of Neuroscience and Experimental Therapeutics, Texas A&M University College of Medicine, Bryan, TX 77807, USA.
- Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
ORCID-Profile: Chander Peddaboina, Lee A Shapiro
Förderung
- NINDS NIH HHS
- National Institutes of Health (NIH)
- Baylor Scott and White Foundation
Zitieren
APA
Peddaboina, C., Iannucci, J., Tobin, R. P., Shapiro, L. A., & Newell Rogers, M. K. (2025). Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136054
Vancouver
Peddaboina C, Iannucci J, Tobin RP, Shapiro LA, Newell Rogers MK. Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136054
BibTeX
@article{Peddaboina2025,
author = {Peddaboina, Chander and Iannucci, Jaclyn and Tobin, Richard P and Shapiro, Lee A and Newell Rogers, M Karen},
title = {Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136054}
}
EUVIMED